CAR-T: Technology, Process, and Validation Student Poster Competition

April 16, 2019
Rutgers University, Richard Weeks Hall of Engineering,Busch Campus
Piscataway, NJ


Chimeric antigen receptor (CAR) T cell therapies are being investigated to provide patients with hematologic cancers an alternative treatment using the immune system. These biological products are unique in that they are produced by adding chimeric antigen receptors (CARs) to a patient’s T cells; the CAR can recognize and attack cells that display particular protein (antigen), including cancer cells.

The author will present a high level summary of CAR T cell therapy, basic considerations during process development and process validation activities.


Dr. Humberto Vega, Sr. Director of Celgene, S12 CAR T Manufacturing Science & Technology, Summit, NJ 


  • 2:30pm - 3:45pm Students arrive and set-up
  • 4:00pm - 5:45pm Student Poster Judging
  • 4:45pm - 5:45pm Networking Reception
  • 6:00pm - 7:00pm Presentation
    "CAR-T: Technology, Process. and Validation" by Humberto Vega, PhD, Celgene
  • 7:00pm - 7:30pm Awards
  • 7:30pm - 8:00pm Wrap up and Conclusion


  • Members - $40
  • Non-Members - $50
  • Young Professionals - $20
  • Student Members - FREE

Bring a non-member guest and receive a $25 gift card!

Sponsorship's Available:

Silver Sponsor - $250
One free registration, recognition on announcements, at the event, in newsletter

Gold Sponsor - $500
Two free registrations, recognition on announcements, at the event, in newsletter

Sponsor early for the maximum exposure!

Register Now

Feel free to forward this to your colleagues